Home › Funds › Hikari Power Ltd › TGTX
Hikari Power Ltd position in TGTX
TG THERAPEUTICS INC · Health Care
Hikari Power Ltd reported holding 5,000 shares of TGTX (TG THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$279K, representing 0.06% of its reported portfolio and ranking #29 among its reported holdings. Hikari Power Ltd has disclosed TGTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Hikari Power Ltd's TGTX position evolved
Hikari Power Ltd first disclosed a stake in TGTX in Q2 2026 at 5,000 shares (US$275K). The position peaked in Q3 2026 at 5,000 shares, worth US$279K. Across 2 filings, Hikari Power Ltd held the position steady without any share-count change. The most recent filing (Q3 2026) shows 5,000 shares valued at US$279K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 5.00K | $275.00K | New |
| Q3 2026 | 5.00K | $279.00K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TGTX and 13F data
TGTX (TG THERAPEUTICS INC) is a Health Care company. 48 other funds we track also report a position in TGTX — the largest reported positions include Soleus Capital Management, L.P. (US$160.9M), CONGRESS ASSET MANAGEMENT CO (US$145.4M), Opaleye Management Inc. (US$29.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TGTX
- Soleus Capital Management, L.P. 2.93M sh · $160.86M · Q2 2026
- CONGRESS ASSET MANAGEMENT CO 2.61M sh · $145.39M · Q3 2026
- Opaleye Management Inc. 535.00K sh · $29.39M · Q2 2026
- Penn Capital Management Company, LLC 480.88K sh · $26.88M · Q3 2026
- Occam Crest Management LP 425.00K sh · $22.73M · Q2 2026
- 683 Capital Management, LLC 389.08K sh · $21.38M · Q2 2026
More on Hikari Power Ltd
FAQ
How long has Hikari Power Ltd held TGTX?
Hikari Power Ltd has disclosed TGTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Hikari Power Ltd's current position in TGTX?
As of Q3 2026, Hikari Power Ltd holds 5.00K shares of TGTX (TG THERAPEUTICS INC), valued at $279.00K, representing 0.06% of its reported portfolio and ranking #29.
Has Hikari Power Ltd been buying or selling TGTX?
In the latest 13F filing (Q3 2026), Hikari Power Ltd held unchanged its position in TGTX. The position peaked in Q3 2026 at 5.00K shares.
Which other funds hold TGTX?
Other major institutional holders of TGTX include Soleus Capital Management, L.P., CONGRESS ASSET MANAGEMENT CO, Opaleye Management Inc., among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.